Permissive Cardiotoxicity The Clinical Crucible of Cardio-Oncology

Overview of attention for article published in JACC: CardioOncology, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 663)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 87 X users
facebook: 1 Facebook page

video: 1 YouTube creator
guideline: 2 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 60 Mendeley

So far, Altmetric has seen 105 X posts from 87 X users, with an upper bound of 471,395 followers.

Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology | JACC: CardioOncology https://t.co/eSCuoGQMxL

IN THE KNOW Understanding how to balance effective cancer treatment with cardiovascular safety is at the heart of cardio-oncology. Read more: https://t.co/dIfoM645gO Porter, C., Azam, T., Mohananey, D. et al. J Am Coll Cardiol CardioOnc. 2022; 4(3): 302–…

RT @drbennisahmed: Permissive Cardiotoxicity emphasizes that rather than calling for cessation of cardiotoxic treatment, the managing card…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 101 additional X posts.